Ken‐ichi Ogawara - Concepedia

Author

Ken‐ichi Ogawara

Also Known As

K OGAWARA, K Ogawara, K. Ogawara, K.-I. Ogawara, K.I. Ogawara, Ken-Ichi Ogawara, Ken-ichi OGAWARA, Ken-ichi Ogawara, Ken‐Ichi Ogawara, Ken‐ichi Ogawara

145

Publications

3.6K

Citations

H-Index

114

Concepts

All Affiliations

Okayama University Kyoto Pharmaceutical University Kyoto University Kobe Pharmaceutical University Shujitsu University

About

Ken‐ichi Ogawara is an author at Okayama University specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	55	2.1K
2	Health Sciences	9	9	252
3	Engineering	8	8	809
4	Natural Sciences	2	2	71
5	Public Health	1	1	10

Ken‐ichi Ogawara

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics Susumu Nagayama, Ken‐ichi Ogawara, Yoshiko Fukuoka, International Journal of Pharmaceutics NanomedicineOpsonin AmountTime-dependent ChangesEngineeringHepatology	2007	223
Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles Ken‐ichi Ogawara, Kentaro Furumoto, Susumu Nagayama, Journal of Controlled Release NanoparticlesNanomedicineEngineeringSerum AlbuminNanomaterials	2004	192
Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use Chomchan Amnuaikit, Itsue Ikeuchi, Ken‐ichi Ogawara, International Journal of Pharmaceutics EngineeringPolymer ScienceTopical DrugSkin PharmacologyDermatology	2004	160
Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers Tamer M. Shehata, Ken‐ichi Ogawara, Kazutaka Higaki, International Journal of Pharmaceutics Lipid PreparationEngineeringResidence TimeMicelleAmphiphilic System	2008	143
PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy Yuta Yoshizawa, Yusuke Kono, Ken‐ichi Ogawara, International Journal of Pharmaceutics Lipid PreparationDrug TargetingPolymer-drug ConjugateVivo DispositionMedicine	2011	141
Hepatic uptake of polystyrene microspheres in rats: Effect of particle size on intrahepatic distribution Ken‐ichi Ogawara, Minoru Yoshida, Kazutaka Higaki, Journal of Controlled Release HepatologyMedicineLiver PhysiologyHepatic UptakeHepatotoxicity	1999	135
A Novel Strategy to Modify Adenovirus Tropism and Enhance Transgene Delivery to Activated Vascular Endothelial Cells <i>In Vitro</i> and <i>In Vivo</i> Ken‐ichi Ogawara, Marianne G. Rots, Robbert J. Kok, Human Gene Therapy	2004	128
In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells Ken‐ichi Ogawara, Keita Un, Ken-ichi Tanaka, Journal of Controlled Release Tumor BiologyOncologyDox-resistant Tumor-bearing MicePeg Liposomal DoxorubicinMedicine	2008	100
Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: Importance of vascular permeability within tumors Ken‐ichi Ogawara, Keita Un, K MINATO, International Journal of Pharmaceutics Vascular PermeabilityTumor BiologyVivo Anti-tumor EffectsOncologyAngiogenesis	2008	89
Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition Kentaro Furumoto, J YOKOE, Ken‐ichi Ogawara, International Journal of Pharmaceutics Lipid PreparationNanomedicineProteinlipid InteractionBiochemistryVivo Disposition	2006	79

Page 1